Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Muccino, David
54  Ergebnisse:
Personensuche X
?
1

Improvements in Objective and Subjective Measures of Chroni..:

Smith, Jaclyn A. ; Birring, Surinder S. ; Dicpinigaitis, Peter V....
Lung.  200 (2022)  4 - p. 423-429 , 2022
Link: https://doi.org/10.1007/..
 
?
2

Leicester Cough Questionnaire validation and clinically imp..:

Nguyen, Allison Martin ; Schelfhout, Jonathan ; Muccino, David...
Therapeutic Advances in Respiratory Disease.  16 (2022)  - p. 175346662210997 , 2022
Link: https://doi.org/10.1177/..
 
?
3

Comparisons Of Baseline Characteristics And Treatment Effic..:

Blaiss, Michael ; Dicpinigaitis, Peter ; Birring, Surinder...
Journal of Allergy and Clinical Immunology.  149 (2022)  2 - p. AB20 , 2022
Link: https://doi.org/10.1016/..
 
?
4

A phase 3, randomized, double-blind, clinical study to eval..:

Niimi, Akio ; Sagara, Hironori ; Kikuchi, Masashi...
Allergology International.  71 (2022)  4 - p. 498-504 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Comorbid Conditions and Medical History Among Patients with..:

Dicpinigaitis, Peter ; Birring, Surinder ; McGarvey, Lorcan...
Journal of Allergy and Clinical Immunology.  147 (2021)  2 - p. AB61 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Validation of a visual analog scale for assessing cough sev..:

Martin Nguyen, Allison ; Bacci, Elizabeth D. ; Vernon, Margaret...
Therapeutic Advances in Respiratory Disease.  15 (2021)  - p. 175346662110497 , 2021
Link: https://doi.org/10.1177/..
 
?
7

Cough Triggers and Symptoms Among Patients with Refractory ..:

Morice, Alyn ; Birring, Surinder ; Dicpinigaitis, Peter...
Journal of Allergy and Clinical Immunology.  147 (2021)  2 - p. AB61 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Patient characteristics and triggers eliciting refractory c..:

Muccino, David ; Philip, George ; Birring, S.S....
World Allergy Organization Journal.  13 (2020)  8 - p. 100209 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Evaluation of co-morbid conditions among refractory or unex..:

Sher, Mandel ; Birring, Surinder ; Morice, Alyn...
Journal of Allergy and Clinical Immunology.  145 (2020)  2 - p. AB209 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Rationale and design of two, phase 3, randomized controlled..:

Muccino, David ; Philip, George ; Morice, A.H....
World Allergy Organization Journal.  13 (2020)  8 - p. 100203 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Defining Minimal Clinically Important Differences (MCID) in..:

Nguyen, Allison M. ; Muccino, David ; Birring, Surinder...
Journal of Allergy and Clinical Immunology.  143 (2019)  2 - p. AB169 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Update on the clinical development of gefapixant, a P2X3 re..:

Muccino, David ; Green, Stuart
Pulmonary Pharmacology & Therapeutics.  56 (2019)  - p. 75-78 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Defining Minimal Clinically Important Differences (MCID) on..:

Birring, Surinder ; Muccino, David ; Bacci, Elizabeth D...
Journal of Allergy and Clinical Immunology.  143 (2019)  2 - p. AB52 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Evaluation of Cough Triggers Among Responders and Non-Respo..:

Sher, Mandel R. ; Birring, Surinder ; Smith, J....
Journal of Allergy and Clinical Immunology.  143 (2019)  2 - p. AB216 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Modification of gene activity in mouse embryos in utero by ..:

Danielian, Paul S. ; Muccino, David ; Rowitch, David H...
Current Biology.  8 (1998)  24 - p. 1323-S2 , 1998
Link: https://doi.org/10.1016/..
 
1-15